Andere talen Lipidor AB

Aandelen

LIPI

SE0012558617

Beurs gesloten - Nasdaq Stockholm Andere beurzen 17:29:36 02-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,243 ^SEK	-0,82%		+2,97%	-51,79%

21/03	Lipidor AB (publ) kondigt goedkeuring aan voor start van Fase III klinische studie van psoriasiskandidaat AKP02G2	CI
28/02	Lipidor AB (publ) rapporteert resultaten voor het vierde kwartaal en het volledige jaar eindigend op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Lipidor AB announces new date for publication of Annual Report 2023	22/04
NOTICE OF EXTRAORDINARY GENERAL MEETING IN LIPIDOR AB (PUBL)	10/04
Lipidor resolves on a rights issue of approximately SEK 58.0 million and enters into a co-investment agreement which secures funding for the implementation of the upcoming phase III study	10/04
Lipidor completes planned divestment of shares in Emollivet	26/03
Lipidor announces approval for start of Phase III clinical trial of psoriasis candidate AKP02G2	21/03
Lipidor AB Announces Approval for Start of Phase III Clinical Trial of Psoriasis Candidate AKP02G2	21/03
Lipidor adds capital through sale of shares	06/03
Lipidor AB (publ) publishes year-end report for 2023	28/02
Lipidor AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	28/02
Lipidor completes SEK 1.7 million sale of animal segment patent	24/01
Lipidor adds 1.1 MSEK through sale of shares in associated company and agreement of loan	21/12
Lipidor Seeks Approval for Late-stage Study of Plaque Psoriasis Medicine in India	20/12
Lipidor applies to the Indian Medical Products Agency to start a Phase III study of AKP02G2	20/12
Lipidor Applies to the Indian Medical Products Agency to Start A Phase III study of AKP02G2	20/12
Lipidor presents Nomination Committee	05/12
Lipidor changes Certified Adviser to Carnegie Investment Bank AB (publ)	30/11
Lipidor AB (publ) publishes interim report for Q3 2023	22/11
Lipidor AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	22/11
Lipidor Files New Patent Application for Akvano Technology in EU	27-10-23
Lipidor submits new patent application	27-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lipidor AB

Aandelen

LIPI

SE0012558617

Andere talen

Filters